H

HCW Biologics

30 employees

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Aging; Immunotherapeutic
Health Care

Date founded

2018

Funding rounds raised

Total raised

$15M

from 2 investors over 2 rounds

H

HCW Biologics raised $15M on August 30, 2020

Investors: FAN Fund

H

HCW Biologics raised $13M on June 10, 2019

Investors: FAN Fund

FAQ